| http://www.w3.org/ns/prov#value | - The invention is also applicable to antibody fragments that are capable of binding to a therapeutic target. [0035] In one embodiment, a compound (which may be a peptide or other molecule that is capable of binding to the ACS of the antibody) is reversibly bound to the antibody binding or combining site of the antibody that is to be administered to a person.
|
